Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03474003 · ClinicalTrials.gov registry record
Development and Validation of a Multidimensional Score to Predict Long-term Kidney Transplant Outcomes
A clinical trial, sponsored by Paris Translational Research Center for Organ Transplantation.
- Completed
- Registry status
- 7,557
- Enrollment target
NCT03474003 is a clinical trial that has completed, run by Paris Translational Research Center for Organ Transplantation. The registered enrollment target is 7,557 participants.
The verdict
NCT03474003 has completed, sponsored by Paris Translational Research Center for Organ Transplantation.
- COMPLETED
- Registry status
- 7,557 participants
- Enrollment target
Study Summary
To further develop personalized medicine in kidney transplantation and improve transplant patient outcomes, attention has been given to define early surrogate endpoints that might aid therapeutic interventions, clinical trials and clinical decision-making. Despite a clear pressing need, no population-scale prognostication system exists that will combine traditional factors and biomarker candidates to represent the complete spectrum of risk predicting parameters. To adequately predict transplant patients' individual risks of allograft loss, this would require a complex integration of data, including: donor data, recipient characteristics, transplant characteristics, allograft precision phenotypes, ethnicity, immunosuppressive regimen monitoring, allograft infections, acute kidney injuries, and recipient immune profiles. This project aims: 1. To develop a generalizable, transportable, mechanistically and data driven composite surrogate end point in kidney transplantation; 2. To validate several risk scores to predict kidney allograft survival and response to treatment of individual patients; Eventually, it will provide an easily accessible tool to calculate individual patients' risk profiles after kidney transplantation, by using datasets from prospective cohorts and post hoc analysis of randomized control trial datasets.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,557 participants |
| Start Date | 2002-01 |
| Est. Completion | 2020-04-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03474003
The ClinicalTrials.gov registry entry for NCT03474003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,557 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paris Translational Research Center for Organ Transplantation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT03474003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03474003 about?
NCT03474003 is a clinical study titled "Development and Validation of a Multidimensional Score to Predict Long-term Kidney Transplant Outcomes". To further develop personalized medicine in kidney transplantation and improve transplant patient outcomes, attention has been given to define early surrogate endpoints that might aid therapeutic interventions, clinical trials and clinical decision-making. Despite a clear pressing need, no populati...
What is the current status of trial NCT03474003?
This trial is currently completed. The enrollment target is 7,557 participants. The study started on 2002-01. Estimated completion is 2020-04-29.
What interventions are being tested in trial NCT03474003?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT03474003?
This trial is sponsored by Paris Translational Research Center for Organ Transplantation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.